Strategy rose nearly 6% in pre-market trading after MSCI stated it would not proceed with its plan to exclude digital asset firm Treasury from its index; biotech company Ventyx Biosciences surged more than 70% on reports that Eli Lilly is close to finalizing an acquisition of the company.